Le Lézard
Classified in: Health
Subjects: AWD, PER

LUTRONIC's Haelyung Hwang named "Top CEO" in the 2018 Aesthetic Everything® Awards


BOSTON, Nov. 13, 2018 /PRNewswire/ -- Lutronic's Chief Executive Officer Haelyung Hwang, was honored in the Aesthetic Everything's 2018 Aesthetic and Cosmetic Medicine Awards.  Mr. Hwang was voted overall "Top CEO" by over 30,000 votes that were cast by the aesthetic industry. The award acknowledges excellence in the field of aesthetics and spans the categories of companies, products, CEOs, doctors, nurses, aestheticians, and several more.

To further expedite global expansion and customer relations, Hwang recently established direct offices in Germany, France and China.  Pictured: Haelyung Hwang ? CEO, Jinyoung Cheong ? VP General Affairs, Hauke Harms ? Lutronic Medical Systems Germany GmbH, Managing Director, Djamel Kemiche ? Lutronic France, General Manager, Aileen Ren ? Lutronic China, General Manager, Jeff Knight ? Lutronic Global, President, Chris Geberth ? Lutronic Global, CFO, Lee Pannell ? Lutronic Global, COO

"I am very honored to accept the Top CEO 2018 Aesthetic Everything® award from my colleagues and peers," said Haelyung Hwang, CEO and Chairman, Lutronic.  "We are ushering in a new era of innovative technology that will revolutionize the healthcare industry. Our new intelligent devices are focused on ensuring the physician can provide best-in-class care for their patients."

About Haelyung Hwang

Haelyung Hwang, CEO and Chairman, Lutronic Corporation, has dedicated his life towards developing quality medical lasers in order to better the lives of patients worldwide. After graduating from Yale University, in 1997 he founded what is now known as Lutronic and in less than a decade took the company public. He partnered with leading physicians and engineers in order to develop the Spectra VRM, which is now the top selling Q-switched Nd:YAG laser in the entire world. 

With a focus on excellence, he has received a variety of global awards and accommodations including Presidential Merit Awards in South Korea for his continuing dedication to furthering the overall market. His vision for developing intelligent systems that improve physicians' ability to care for patients has led to innovation in ophthalmology, spinal and other surgical fields.

His dedication to developing effective, reliable systems has elevated Lutronic into the first or second position in almost every Asian market. This year, Mr. Hwang turned his focus on elevating Lutronic to become a top worldwide company by hiring an experienced executive management team and establishing Lutronic Global headquarters in Boston, MA. To further expedite global expansion and customer relations, he recently established direct offices in Germany, France and China.  

Under Mr. Hwang's leadership, Lutronic earned 7 additional awards this year ? including Top Aesthetic Company, Top Aesthetic Laser Manufacturer, Top New FDA-Cleared Innovation, and Top Skin Care Devices. He continues to push Lutronic towards the future through innovative thinking and sound business decisions. 

About Aesthetic Everything:

With almost ten years in business, Aesthetic Everything is the largest network of aesthetic and beauty professionals in the world. This is the seventh year that Aesthetic Everything has presented hundreds of awards to deserving and hard-working professionals and companies within the aesthetic industry. The company's success is rooted in their over 200,000 aesthetic industry subscribers and over 1 million engaged social media connections.

Aesthetic Everything has been featured in numerous publications including ABC, NBC, FOX, CBS, WSJ, Entertainment Tonight, Good Morning America, Radar Online, Haute Living, Life and Style, E! Online, Reality Tea, OK! Magazine, US Weekly, AOL, Naluda Magazine, Inform New York, Getty Images, Yahoo, Scottsdale Health, Modern Luxury Magazine, Pop Sugar and has also been mentioned in millions of websites and publications worldwide.

About LUTRONIC

Dedicated to advancing the fields of Aesthetic, Ophthalmology, Surgical laser and energy-based medicine, Lutronic develops intelligent systems that are innovative, intuitive, dependable and effective to improve a physician's ability to provide outstanding patient care. Committed to this mission since 1997, Lutronic partners with key opinion leaders to advance science and ensure the efficacy of its systems.  Systems include proprietary features which enhance versatility and expand treatment options for optimized outcomes.

Focused on engineering devices that offer unique features and improvements not found in today's market, Lutronic devotes 20 percent of revenues to R&D and holds more than 493 current and pending patents worldwide. With Lutronic Global located in the U.S. Boston area, Lutronic also has a major manufacturing office in Korea, offices in Germany, France, China and Japan and a worldwide network of direct sales teams and distributors that is ever expanding. For more information on Lutronic visit https://us.aesthetic.lutronic.com

MEDIA CONTACT:
Jennifer Rice
Lutronic Global
865-386-3662
[email protected]

Haelyung Hwang, CEO and Chairman, Lutronic Corporation was voted overall

SOURCE Lutronic


These press releases may also interest you

at 00:39
World Malaria Day is marked each year on April 25. World Health Organization (WHO) gave as the theme for World Malaria Day 2024 Accelerating the fight against malaria for a more equitable world. WHO stated that malaria not only continues to directly...

25 avr 2024
The report titled "Anti-Adhesion Products Market by Product Type (Natural Adhesion Barriers, Synthetic Adhesion Barriers), Product Form (Film Formulation, Gel Formulation, Liquid Formulation), Application, End-User - Global Forecast 2024-2030" is now...

25 avr 2024
Product: Meat and vegetable products Issue: Food - Microbial Contamination - Listeria Distribution:British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

25 avr 2024
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

25 avr 2024
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....

25 avr 2024
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...



News published on and distributed by: